Publication:
SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021).

Simple item page
dc.contributor.authorde la Haba-Rodriguez, Juan
dc.contributor.authorLloret, Ferran Ferragut
dc.contributor.authorSalgado, Maria Angeles Vaz
dc.contributor.authorArce, Marin Ore
dc.contributor.authorGutierrez, Ana Cardeña
dc.contributor.authorJimenez, Jesus Garcia-Donas
dc.contributor.authorZambrano, Carmen Beato
dc.contributor.authorAlonso, Rosa Maria Rodriguez
dc.contributor.authorLopez, Rafael Lopez
dc.contributor.authorSalas, Nuria Rodriguez
dc.date.accessioned2023-05-03T14:00:42Z
dc.date.available2023-05-03T14:00:42Z
dc.date.issued2022-02-22
dc.description.abstractThe improvement of molecular alterations in cancer as well as the development of technology has allowed us to bring closer to clinical practice the determination of molecular alterations in the diagnosis and treatment of cancer. The use of multidetermination platforms is spreading in most Spanish hospitals. The objective of these clinical practice guides is to review their usefulness, and establish usage guidelines that guide their incorporation into clinical practice.
dc.description.versionSi
dc.identifier.citationde la Haba-Rodriguez J, Lloret FF, Salgado MAV, Arce MO, Gutiérrez AC, Jiménez JG, et al. SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021). Clin Transl Oncol. 2022 Apr;24(4):693-702
dc.identifier.doi10.1007/s12094-022-02817-8
dc.identifier.essn1699-3055
dc.identifier.pmcPMC8986692
dc.identifier.pmid35362851
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986692/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s12094-022-02817-8.pdf
dc.identifier.urihttp://hdl.handle.net/10668/21141
dc.issue.number4
dc.journal.titleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
dc.journal.titleabbreviationClin Transl Oncol
dc.language.isoen
dc.organizationÁrea de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
dc.organizationHospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC
dc.page.number693-702
dc.publisherSpringer
dc.pubmedtypeJournal Article
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s12094-022-02817-8
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectBiomarkers
dc.subjectMolecular platforms
dc.subjectNext-generation sequencing
dc.subjectPrecision medicine
dc.subjectÁrea de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
dc.subject.decsHospitales
dc.subject.decsNeoplasias
dc.subject.decsTecnología
dc.subject.meshNeoplasms
dc.subject.meshHospitals
dc.subject.meshTechnology
dc.titleSEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021).
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number24
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC8986692.pdf
Size:
803.11 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Reina Sofía
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
SAS - Hospital Universitario de Jerez de la Frontera

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía